Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 131.81 Million HKD | 27.87% |
| 2022 | 103.08 Million HKD | -19.77% |
| 2021 | 128.47 Million HKD | 21.19% |
| 2020 | 106.01 Million HKD | 6.14% |
| 2019 | 99.87 Million HKD | 8093.19% |
| 2018 | 1.21 Million HKD | 101.49% |
| 2017 | 605 Thousand HKD | 8.81% |
| 2016 | 556 Thousand HKD | -0.89% |
| 2015 | 561 Thousand HKD | 0.0% |
| 2014 | - HKD | 0.0% |
| 2013 | - HKD | 0.0% |
| 2012 | - HKD | 0.0% |
| 2011 | - HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 249 Thousand HKD | 53701.2% |
| 2024 Q1 | 249 Thousand HKD | -99.81% |
| 2023 Q2 | 128.45 Million HKD | 67.55% |
| 2023 FY | 131.81 Million HKD | 27.87% |
| 2023 Q1 | 76.67 Million HKD | -25.62% |
| 2023 Q4 | 131.81 Million HKD | 74.45% |
| 2023 Q3 | 75.55 Million HKD | -41.18% |
| 2022 Q1 | 62.69 Million HKD | -51.2% |
| 2022 FY | 103.08 Million HKD | -19.77% |
| 2022 Q4 | 103.08 Million HKD | 69.12% |
| 2022 Q3 | 60.95 Million HKD | -44.16% |
| 2022 Q2 | 109.16 Million HKD | 74.13% |
| 2021 Q1 | 75.95 Million HKD | -28.35% |
| 2021 FY | 128.47 Million HKD | 21.19% |
| 2021 Q3 | 75.75 Million HKD | -38.62% |
| 2021 Q4 | 128.47 Million HKD | 69.6% |
| 2021 Q2 | 123.41 Million HKD | 62.48% |
| 2020 Q3 | 65.4 Million HKD | -34.09% |
| 2020 FY | 106.01 Million HKD | 6.14% |
| 2020 Q1 | 62.08 Million HKD | -37.84% |
| 2020 Q2 | 99.23 Million HKD | 59.84% |
| 2020 Q4 | 106.01 Million HKD | 62.08% |
| 2019 Q4 | 99.87 Million HKD | 65.22% |
| 2019 Q2 | 113.4 Million HKD | 65.33% |
| 2019 FY | 99.87 Million HKD | 8093.19% |
| 2019 Q3 | 60.44 Million HKD | -46.7% |
| 2019 Q1 | 68.59 Million HKD | 5526.99% |
| 2018 FY | 1.21 Million HKD | 101.49% |
| 2018 Q4 | 1.21 Million HKD | 0.0% |
| 2018 Q3 | 1.21 Million HKD | 7.02% |
| 2018 Q2 | 1.13 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 Q2 | 596 Thousand HKD | 0.0% |
| 2017 FY | 605 Thousand HKD | 8.81% |
| 2017 Q4 | 605 Thousand HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 Q3 | - HKD | -100.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 556 Thousand HKD | -0.89% |
| 2016 Q4 | 556 Thousand HKD | 0.0% |
| 2016 Q2 | 575 Thousand HKD | 0.0% |
| 2015 Q4 | 561 Thousand HKD | 0.0% |
| 2015 Q2 | 4.31 Million HKD | 0.0% |
| 2015 FY | 561 Thousand HKD | 0.0% |
| 2015 Q1 | - HKD | 0.0% |
| 2014 FY | - HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 Q2 | - HKD | 0.0% |
| 2014 Q1 | - HKD | 0.0% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q2 | - HKD | 0.0% |
| 2013 Q1 | - HKD | 0.0% |
| 2013 FY | - HKD | 0.0% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 FY | - HKD | 0.0% |
| 2011 FY | - HKD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| China Healthwise Holdings Limited | 108.9 Million HKD | -21.04% |
| Tycoon Group Holdings Limited | 206.16 Million HKD | 36.063% |